Insomnia related to postmenopausal syndrome and hormone replacement therapy: Sleep laboratory studies on baseline differences between patients and controls and double-blind, placebo-controlled investigations on the effects of a novel estrogen-progestogen combination (Climodien®, Lafamme®) versus estrogen alone

Journal of Sleep Research

Volumn 12, Issue 3, 2003, Pages 239-254

  Saletu Zyhlarz, Gerda ^a   Anderer, Peter ^a   Gruber, Georg ^a   Mandl, Magdalena ^a   Gruber, Doris ^a   Metka, Markus ^a   Huber, Johannes ^a   Oettel, Michael ^b   Gräser, Thomas ^b   Hassan Abu Bakr, Manal ^c   Grätzhofer, Elisabeth ^a   Saletu, Bernd ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b BAYER PHARMA AG   (Germany)

^c ALEXANDRIA UNIVERSITY   (Egypt)

Author keywords

Estrogen progestogen combination; Hormone replacement therapy; Insomnia; Polysomnography; Postmenopausal syndrome; Psychometry

Indexed keywords

DIENOGEST PLUS ESTRADIOL VALERATE; ESTRADIOL; ESTROGEN; LAFAMME; PLACEBO;

ADULT; APNEA; AROUSAL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MEMORY; MENOPAUSAL SYNDROME; MOTOR ACTIVITY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SLEEP DISORDER; TREATMENT OUTCOME; WAKEFULNESS; WELLBEING;

AGED; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MEMORY; MIDDLE AGED; NANDROLONE; POLYSOMNOGRAPHY; POSTMENOPAUSE; REACTION TIME; SEVERITY OF ILLNESS INDEX; SLEEP APNEA SYNDROMES; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP, REM; WAKEFULNESS;

EID: 10744220386     PISSN: 09621105     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2869.2003.00356.x     Document Type: Article

References (86)

1. Abt, K. Descriptive data analysis (DDA) in quantitative EEG studies. In: D. Samson-Dollfus, J. D. Guieu, J. Gotman and P. Etevenon (Eds) Statistics and Topography in Quantitative EEG. Elsevier, Amsterdam, 1988: 150-160.
2. Anderer, P., Gruber, G., Klösch, G., Saletu, B., Barbanoj, M. J., Danker-Hopfe, H., Himanen, S. L., Kemp, B., Penzel, T., Röschke, J. and Dorffner, G. Effects of normal aging on subjective and objective measures of sleep. J. Sleep Res., 2000, 9 (Suppl. 1): 4.
3. Anderer, P., Semlitsch, H. V., Saletu, B., Saletu-Zyhlarz, G. M., Gruber, D., Metka, M. and Huber, J. Effects of hormone replacement therapy on perceptual and cognitive event-related potentials in menopausal insomnia. Psychoneuroendocrinology, 2003, 28: 419-445.
4. Antonijevic, I. A., Stalla, G. K. and Steiger, A. Modulation of sleep electroencephalogram by estrogen replacement in postmenopausal women. Am. J. Obstet. Gynecol., 2000, 182: 277-282.
5. Asplund, R. and Aberg, H. E. Body mass index and sleep in women aged 40 to 64 years. Maturitas, 1995, 22: 1-8.
6. Atlas Task Force of ASDA. Recording and scoring leg movements. Sleep, 1993, 16: 748-759.
7. Ballinger, C. B. Psychiatric morbidity and the menopause: screening of a general population sample. Br. Med. J., 1975, 9: 344-346.
8. Baumgartner, A., Dietzel, M., Saletu, B., Wolff R., Campos-Barros, A., Gräf, K.J., Kürten, I. and Mannsmann, U. Influence of partial sleep deprivation on the secretion of thyrotropin, thyroid hormones, growth hormone, prolactin, luteinizing hormone, follicle stimulating hormone and estradiol in healthy young women. Psychiatry Res., 1993, 48: 153-178.
9. Bixler, E., Kales, A., Soldatos, C., Kales, J. and Healy, S. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am. J. Psychiatry, 1979, 136: 1257-1262.
10. Bixler, E. O., Vgontzas, A. N., Lin, H. M., Ten-Have, T., Leiby, B. E., Vela-Bueno, A. and Kales, A. Association of hypertension and sleep-disordered breathing. Arch. Intern. Med., 2000, 160: 2289-2295.
11. Bixler, E. O., Vgontzas, A. N., Lin, H. M., Ten-Have, T., Rein, J., Vela-Bueno, A. and Kales, A. Prevalence of sleep-disordered breathing in women: effects of gender. Am. J. Respir. Crit. Care Med., 2001, 163: 608-613.
12. Block, A. J., Wynne, J. W., Boysen, P. G., Lindsey, S., Martin, C. and Canton, B. Menopause, medroxyprogesterone and breathing during sleep. Am. J. Med., 1981, 70: 506-510.
13. Brodeur, P., Mockus, M., Mc Cullough, R. G. and Moore, L. G. Progesterone receptors and ventilatory stimulation by progestin. J. Appl. Physiol., 1986, 60: 590-595.
14. Buysse, D. J., Reynolds, C. F., III, Monk, T. H., Berman, S. R. and Kupfer, D. J. The Pittsburgh sleep quality index. A new instrument for psychiatric practice and research. Psychiatry Res., 1989, 28: 193-213.
15. Campbell, S. Double-blind psychometric studies on the effects of natural oestrogens on postmenopausal women. In: S. Campbell (Ed.) Management of the Menopause and the Postmenopausal Years. MTP Press, Lancaster, 1977: 149-158.
16. Crown, S. and Crisp, A. H. Manual of the Crown-Crisp Experiential Index. Hodder and Stoughton, London, 1979.
17. Dietzel, M., Saletu, B., Lesch, O. M., Sieghart, W. and Schjerve, M. Light treatment in depressive illness. Polysomnographic, psychometric and neuroendocrinological findings. Eur. Neurol., 1986, 25 (Suppl. 2): 93-103.
18. Dolly, F. R. and Block, A. J. Medroxyprogesterone acetate and COPD: effect on breathing and oxygenation in sleeping and awake patients. Chest, 1983, 4: 394-398.
19. Empson, J. A. and Purdie, D. W. Effects of sex steroids on sleep. Ann. Med., 1999, 31: 141-145.
20. Erlik, Y., Tataryn, I. V. and Meldrum, D. R. Association of waking episodes with menopausal hot flushes. JAMA, 1981, 245: 1741-1744.
21. Feinberg, I. Effects of age on human sleep patterns. In: A. Kales (Ed.) Sleep Physiology and Pathology. Lippincott, Philadelphia, 1969: 39-52.
22. Grünberger, J. Psychodiagnostik des Alkoholkranken. Ein methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie. Maudrich, Wien, 1977.
23. Hunter, M. S. Psychological and somatic experience of the menopause: a prospective study. Psychosom. Med. 1990, 52: 357-367.
24. Hunter, M. The South-East England longitudinal study of the climacteric and postmenopause. Maturitas 1992, 14: 117-126.
25. Hunter, M., Battersby, R. and Whitehead, M. Relationships between psychological symptoms, somatic complaints and menopausal status. Maturitas, 1986, 8: 217-228.
26. Jasmann, N. D., Van Lith, N. D. and Zaat, J. C. A. The perimenopausal symptoms: the statistical analysis of a survey. Med. Gynaecol. Sociol., 1969, 10: 268-277.
27. Jean-Louis, G., Kripke, D. F., Assmus, J. D. and Langer, R. D. Sleep-wake patterns among postmenopausal women: a 24-hour unattended polysomnographic study. J. Gerontol. A Biol. Sci. Med. Sci., 2000, 55: M120-M123.
28. Kales, A., Caldwell, A., Cadieux, R., Velo-Bueno, A., Ruch, L. and Mayes, S. Severe obstructive sleep apnea: associated psychopathology and psychological consequences. J. Chronic Dis., 1985, 36: 427-434.
29. Karacan, I., Thornby, J., Anch, M., Holzer, C., Warheit, G., Schwab, J. and Williams, R. Prevalence of sleep disturbances in a primarily urban Florida country. Soc. Sci. Med., 1976, 10: 239-244.
30. Keefe, D. L., Watson, R. and Naftolin, F. Hormone replacement therapy may alleviate sleep apnea in menopausal women: a pilot study. Menopause, 1999, 6: 196-200.
31. Kujak, J. and Young, T. The average month-to-month effect of menopausal symptoms on sleep complaints. Abstract Book, 11th Annual Meeting - Associated Professional Sleep Studies, San Francisco, 1997: 384.
32. Kupperman, H. S. Contemporary therapy of the menopausal syndrome. JAMA, 1959, 171: 1627-1637.
33. Linzmayer, L., Semlitsch, H. V., Saletu, B., Böck, G., Saletu-Zyhlarz, G., Zoghlami, A., Gruber, D., Metka, M., Huber, J., Oettel, M., Gräser, T. and Grünberger, J. Double-blind, placebo-controlled psychometric studies on the effects of a combined estrogen-progestin regimen versus estrogen alone on performance, mood and personality of menopausal syndrome patients. Arzneim. Forsch. Drug Res., 2001, 51: 238-245.
34. Lugaresi, E., Cirignotta, F. and Zucconi, M. Good and poor sleepers: an epidemiological survey of San Marino population. In: C. Guilleminault and E. Lugaresi (Eds) Sleep/Wake Disorders: Natural History, Epidemiology, and Long-term Evolution. Raven Press, New York, 1983.
35. Lyons, H. A. and Antonio, R. The sensitivity of the respiratory center in pregnancy and after the administration of progesterone. Trans. Assoc. Am. Phys., 1959, 72: 173-180.
36. Manber, R. and Armitage, R. Sex, steroids, and sleep: a review. Sleep, 1999, 22: 540-555.
37. Millman, R., Pogel, B., Mc Namara, M. and Carliste, C. Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous airway pressure. J. Clin. Psychiatry, 1989, 50: 348-351.
38. Moe, K. E. Reproductive hormones, aging, and sleep. Semin. Reprod. Endocrinol., 1999, 17: 339-348.
39. Montplaisir, J., Lorrain, J., Denesle, R. and Petit, D. Sleep in menopause: differential effects of two forms of hormone replacement therapy. Menopause, 2001, 8: 10-16.
40. Orr, W. C., Imes, N. K. and Martin, R. J. Progesterone therapy in obese patients with sleep apnea. Arch. Intern. Med., 1979, 139: 109-111.
41. Owens, J. F. and Mathews, K. A. Sleep disturbance in healthy middle-aged women. Maturitas, 1998, 30: 41-50.
42. Partien, M. and Guilleminault, C. Daytime sleepiness and vascular morbidity at seven year follow-up in obstructive sleep apnea patients. Chest, 1990, 97: 27-32.
43. Pickett, C. K., Regensteiner, J. G., Woodard, W. D., Hagerman, D. D., Weil, J. V. and Grindlay Moore, L. Progestin and estrogen reduce sleep-disordered breathing in postmenopausal women. J. Appl. Physiol., 1989, 66: 1656-1661.
44. Polo-Kantola, P., Erkkola, R., Helenius, H., Irjala, K. and Polo, O. When does estrogen replacement therapy improve sleep quality? Am. J. Obstet. Gynecol., 1998, 178: 1002-1009.
45. Polo-Kantola, P., Erkkola, R., Irjala, K., Pullinen, S., Virtanen, I. and Polo, O. Effect of short-term transdermal estrogen replacement therapy on sleep: a randomized, double-blind crossover trial in postmenopausal women. Fertil. Steril., 1999, 71: 873-880.
46. Purdie, D. W., Empson, J. A., Crichton, C. and Macdonald, L. Hormone replacement therapy, sleep quality and psychological wellbeing. Br. J. Obstet. Gynaecol., 1995, 102: 735-739.
47. Rajagopal, K. R., Albrecht, P. H. and Jabbari, B. Effects of medroxyprogesterone acetate in obstructive sleep apnea. Chest, 1986, 90: 815-821.
48. Rao, B. R., Wiest, N. S. and Allen, W. M. Progesterone "receptor" in rabbit uterus. I. Characterization and estradiol-17β augmentation. Endocrinology, 1973, 92: 1229-1240.
49. Rechtschaffen, A. and Kales, A. A Manual of Standardized Terminology, Technique and Scoring System for Sleep Stages. Brain Information Service, University of California, 1968.
50. Reynolds, C. F. and Kupfer, D. J. Sleep research in affective illness: state of the art. Sleep, 1987, 10: 199-215.
51. Rumback, L., Krieger, J. and Kurtz, D. Auditory event-related potentials in obstructive sleep apnea: effect of treatment with nasal continuous positive airway pressures. Electroencephalogr. Clin. Neurophysiol., 1991, 80: 454-457.
52. Saletu, B. and Saletu-Zyhlarz, G. M. Was Sie schon immer über Schlaf wissen wollten. Ueberreuter, Wien, 2001.
53. Saletu, B., Wessely, P., Grünberger, J. and Schultes, M. Erste klinische Erfahrungen mit einem neuen schlafanstoßenden Benzodiazepin, Cinolazepam, mittels eines Selbstbeurteilungsbogens für Schlaf- und Aufwachqualität (SSA). Neuropsychiatrie, 1987, 1: 169-176.
54. Saletu, B., Anderer, P., Frey, R., Krupka, M. and Klösch, G. Zur Neurophysiologie des Schlafes/Some remarks about the neurophysiology of sleep. Psychiatria Danubina, 1991, 3: 31-58.
55. Saletu, B., Anderer, P., Brandstätter, N., Frey, R., Grünberger, J., Klösch, G., Mandl, M., Wetter, Th. and Zeitlhofer, J. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long-versus a short-half-life benzodiazepine (quazepam versus triazolam). Neuropsychobiology, 1994, 29: 69-90.
56. Saletu, B., Brandstätter, N., Frey, R., Saletu-Zyhlarz, G, Dantendorfer, K., Berger, P. and Löffler, H. Klinik von Schlafstörungen -Erfahrungen über 817 Patienten einer Schlafambulanz. Wien. Klin. Wochenschr., 1997, 109: 390-399.
57. Saletu, B., Löffler, H., Gruber, D., Mandl, M., Gruber, G., Klösch, G., Brandstätter, N., Dantendorfer, K., Frey, R., Saletu-Zyhlarz, G., Metka, M., Huber, J. and Anderer, P. Schlaflaboruntersuchungen zur Insomnie bei postmenopausalem Syndrom. Journal für Menopause, 1998, 4: 29-36.
58. Saletu, B., Gruber, G., Saletu, M., Brandstätter, N., Hauer, C., Prause, W., Ritter, K. and Saletu-Zyhlarz, G. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality. Neuropsychobiology, 2000a, 41: 181-189.
59. Saletu, M., Hauer, C., Anderer, P., Saletu-Zyhlarz, G., Gruber, G., Oberndorfer, S., Mandl, M., Popovic, R. and Saletu, B. Tagesmüdigkeit korreliert mit nächtlichen Atmungs- und Arousal-Variablen bei Schlafapnoepatienten: Polysomnographische und EEG-Mapping-Untersuchungen. Wien. Klin. Wochenschr., 2000b, 112: 281-289.
60. Saletu, M., Anderer, P., Saletu, B., Hauer, C., Mandl, M., Oberndorfer, S., Zoghlami, A. and Saletu-Zyhlarz, G. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables. Neuropsychobiology, 2000c, 41: 190-199.
61. Saletu, M., Anderer, P., Saletu, B., Hauer, C, Mandl, M., Semler, B. and Saletu-Zyhlarz, G. Sleep laboratory studies in periodic limb movement disorder (PLMD) as compared with normals and acute effects of ropinirole. Hum. Psychopharmacol. Clin. Exp., 2001, 16: 177-187.
62. Saletu, B., Anderer, P., Gruber, D., Metka, M., Huber, J. and Saletu-Zyhlarz, G. M. Hormone replacement therapy and vigilance: double-blind, placebo-controlled EEG mapping studies with an estrogen-progestogen regimen (Climodien®, Lafamme®) versus estrogen alone in menopausal insomnia patients. Maturitas, 2002, 43: 165-181.
63. Saletu-Zyhlarz, G., Saletu, B., Anderer, P., Brandstätter, N., Frey, R., Gruber, G., Klösch, G., Mandl, M., Grünberger, J. and Linzmayer, L. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping. Neuropsychobiology, 1997, 36: 117-129.
64. Saletu-Zyhlarz, G. M., Anderer, P., Berger, P., Gruber, G., Oberndoffer, S. and Saletu, B. Nonorganic insomnia in panic disorder: comparative sleep laboratory studies with normal controls and placebo-controlled trials with alprazolam. Hum. Psychopharmacol. Clin. Exp., 2000, 15: 241-254.
65. Saletu-Zyhlarz, G., Hassan Abu-Bakr, M., Semler, B., Decker, K., Parapatics, S., Tschida, U., Winkler, A. and Saletu, B. Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology, 2001, 44: 142-150.
66. Saletu-Zyhlarz, G. M., Hassan Abu-Bakr, M., Anderer, P., Gruber, G., Mandl, M., Strobl, R., Gollner, D., Prause, W. and Saletu, B. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2002, 26: 249-260.
67. Schiff, I., Regestein, Q., Tulchinsky, D. and Ryan, K. J. Effects of estrogen on sleep and psychological state of hypogonadal women. JAMA, 1979, 242: 2405-2407.
68. Schulz, H., Jobert, M., Gee, M. W. and Ashbrook, D. W. Soporific effect of the neurosteroid pregnanolone in relation to the substance's plasma level: a pilot study. Neuropsychobiology, 1996, 34: 106-112.
69. Shaver, J. L. and Zenk, S. N. Sleep disturbance in menopause. J. Women Health Gend. Based Med., 2000, 9: 109-118.
70. Siebler, M. and Nachtmann, A. Cerebral haemodynamics in obstructive sleep apnea. Chest, 1993, 103: 1118-1119.
71. Skatrud, J. B., Dempsey, J. A., Iber, C. and Berssenbrugge, A. Corrections of CO2 retention during sleep in patients with chronic obstructive pulmonary disease. Am. Rev. Respir. Dis., 1981, 124: 260-268.
72. Steiger, A., Trachsel, L., Guldner, J., Hemmeter, U., Rothe, B., Rupprecht, R., Vedder, H. and Holsboer, F. Neurosteroid pregnenolone induces sleep EEG changes in man compatible with inverse agonistic GABA A receptor modulation. Brain Res., 1993, 615: 267-274.
73. Stransky, E. Über krankhafte Ideen. Bergmann, Wiesbaden, 1914.
74. Strauch, I., Dubral, I. and Struchholz, C. Sleep behavior in adolescents in relation to personality variables. In: Jovanovic (Ed) The Nature of Sleep. Fischer, Stuttgart, 1973: 121-131.
75. Strohl, K. P., Hensley, M. J., Sanders, N. A., Scharf, S. M., Brown, R. and Ingram, R. H. G. Progesterone administration and progressive sleep apnea. J. Am. Med. Assoc., 1981, 245: 1230-1250.
76. Teichmann, A. T. (Hrsg). Dienogest - Präklinik und Klinik eines neuen Gestagens. Dienogest [Preclinical and Clinical Characteristics of a New Progestin]. Walter de Gruyter, Berlin/New York, 1995.
77. Thompson, J. and Oswald, I. Effect of estrogen on the sleep, mood and anxiety of menopausal women. Br. Med. J., 1977, 2: 1317-1319.
78. Tribl, G. G., Schmeiser-Rieder, A., Rosenberger, A., Saletu, B., Bolitschek, J., Kapfhammer, G., Katschnig, H., Holzinger, B., Popovic, R., Kunze, M. and Zeitlhofer, J. Sleeping habits in the Austrian population. Sleep Med., 2002, 3: 21-28.
79. Tune, G. A. The influence of age and temperament on the adult human sleep-wakefulness pattern. Br. J. Psychol., 1969, 60: 431-441.
80. Von Zerssen, D., Koeller, D. M. and Rey, E. R. Die Befindlichkeitsskala (B-S) - ein einfaches Instrument zur Objektivierung von Befindlichkeitsstö rungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneim. Forsch. Drug Res., 1970, 20: 915-918.
81. Walsleben, J., O'Malley, E., Bonnet, K., Norman, R. and Rapoport, D. The utility of topographic EEG-mapping in obstructive sleep apnea syndrome. Sleep, 1993, 16: 76-78.
82. Webb, W. B. The different functional relationships of REM and stage 4 sleep. In: Jovanovic (Ed) The Nature of Sleep. Fischer, Stuttgart, 1973: 256-258.
83. Welstein, L., Dement, W., Redington, D., Guilleminault, C. and Mitler, M. Insomnia in the San Francisco Bay area: a telephone survey. In: C. Guilleminault and E. Lugaresi (Eds) Sleep/Wake Disorders: Natural History, Epidemiology and Long-term Evolution. Raven Press, New York, 1983: 73-85.
84. Wiklund, I., Berg, G., Hammer, M., Karlberg, J., Lindgren, R. and Sandin, K. Long-term effect of transdermal hormonal therapy on aspects of quality of life in menopausal women. Maturitas, 1992, 14: 225-236.
85. Zeitlhofer, J., Rieder, A., Kapfhammer, G., Bolitschek, J., Skrobal, A., Holzinger, B., Lechner, H., Saletu, B. and Kunze, M. Zur Epidemiologie von Schlafstörungen in Österreich. Wien. Klin. Wochenschr., 1994, 106: 86-88.
86. Zeitlhofer, J., Schmeiser, A., Kapfhammer, G., Bolitschek, J., Saletu, B. and Kunze, M. Schlafstörungen in Österreich. Neuropsychiatrie, 1996, 10: 43.